News from dipexium pharmaceuticals A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-CM:DPRX)

Feb 04, 2016, 08:00 ET

Dipexium Pharmaceuticals Reaches 75% Enrollment Milestone in Pivotal Phase 3 Clinical Trials

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of...

Feb 01, 2016, 08:00 ET

Dipexium Pharmaceuticals Announces Issuance of Locilex® Patents in Australia and New Zealand

Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of...

Jan 29, 2016, 08:00 ET

Dipexium Pharmaceuticals Announces Presentation at 18th Annual BIO CEO & Investor Conference

 Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late stage pharmaceutical company focused on the development and commercialization of...

Jan 06, 2016, 07:00 ET

Dipexium Pharmaceuticals Announces Presentation at Biotech Showcase™ 2016

 Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late stage pharmaceutical company focused on the development and commercialization of...

Dec 01, 2015, 08:00 ET

Dipexium Pharmaceuticals Announces Presentation at Oppenheimer 26th Annual Healthcare Conference

 Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late stage pharmaceutical company focused on the development and commercialization of...

Nov 16, 2015, 07:00 ET

Dipexium Pharmaceuticals Reports Third Quarter 2015 Financial Results

Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of...

Nov 09, 2015, 08:00 ET

Dipexium Pharmaceuticals to Hold Third Quarter 2015 Financial Results Conference Call on Monday, November 16, 2015, at 8:30 a.m. ET

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX) will release its financial results for the quarter ended September 30, 2015, on Monday, November 16,...

Oct 01, 2015, 09:20 ET

Dipexium Pharmaceuticals Reaches 50% Enrollment in Second Pivotal Phase 3 Clinical Trial

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of...

Sep 21, 2015, 07:00 ET

Dipexium Pharmaceuticals Presents Locilex® Microbiology Data at ICAAC/ICC 2015 Conference

 Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of...

Aug 31, 2015, 08:00 ET

Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September

 Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of...

Aug 20, 2015, 08:00 ET

Dipexium Pharmaceuticals Surpasses Treatment of 50% of Subjects in Pivotal Phase 3 Clinical Trial

 Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of...

Aug 13, 2015, 07:00 ET

Dipexium Pharmaceuticals Reports Second Quarter 2015 Financial Results

 Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of...

Aug 06, 2015, 08:00 ET

Dipexium Pharmaceuticals to Hold Second Quarter 2015 Financial Results Conference Call on Thursday, August 13, 2015, at 8:30 a.m. ET

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX) will release its financial results for the quarter ended June 30, 2015, on Thursday, August 13, 2015...

Jul 28, 2015, 08:00 ET

Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant to other Topical Antibiotics

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of...

Jun 30, 2015, 11:00 ET

Dipexium Announces Closing of Public Offering of Common Stock

Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX), a late stage pharmaceutical company focused on the development and commercialization of...

Jun 25, 2015, 09:12 ET

Dipexium Announces Pricing of Public Offering of Common Stock

 Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX), a late stage pharmaceutical company focused on the development and commercialization of...

Jun 24, 2015, 16:04 ET

Dipexium Announces Proposed Public Offering of Common Stock

Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX), a late stage pharmaceutical company focused on the development and commercialization of...

Jun 02, 2015, 13:22 ET
Jun 02, 2015, 08:49 ET
Jun 02, 2015, 07:00 ET

Dipexium Receives European Medicines Agency Scientific Advice on Clinical and Regulatory Pathway for Locilex® Marketing Approval in European Union

 Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late stage pharmaceutical company focused on the development and commercialization of...